{"id":"W2918649302","doi":"10.3899/jrheum.180718","title":"Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study","year":2019,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"University of California, San Francisco","keywords":"BASFI; Medicine; Ankylosing spondylitis; Golimumab; BASDAI; Placebo; Spondylitis; Crossover study; Internal medicine; Clinical endpoint; Randomized controlled trial; Physical therapy; Disease; Adalimumab","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001836807,0.0004589711,0.001352609,0.0002315769,0.00034626,0.0004637977,0.0003240967,0.0008874223,0.0008048544],"category_scores_gemma":[0.001371971,0.0001715523,0.001043039,0.0002241439,0.000289739,0.0004157636,0.0003031274,0.0009436436,0.000241349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002848982,"about_ca_system_score_gemma":0.0004762419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006150667,"about_ca_topic_score_gemma":0.0009070496,"domain_scores_codex":[0.9995352,0.0002008163,0.00003793706,0.00005806287,0.00009107277,0.00007697211],"domain_scores_gemma":[0.9988886,0.0001793264,0.0004424033,0.00006853765,0.0001221956,0.0002990768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.564542,0.01542088,0.235849,0.001226495,0.004216863,0.0005430677,0.0005238598,0.001283673,0.01573623,0.0001767296,0.003188315,0.1572929],"study_design_scores_gemma":[0.138322,0.2656962,0.5838857,0.000190205,0.003987066,0.0005543391,0.0001768414,0.0007988542,0.001950703,0.0001377938,0.004251027,0.00004917476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995068,0.00344616,0.0001224611,0.000184993,0.00002655437,0.0001456119,0.0005456478,0.00001524345,0.0004454702],"genre_scores_gemma":[0.9971033,0.0009621341,0.0001891823,0.0003050576,0.00007952921,0.0001265537,0.0008050954,0.000003662542,0.0004255554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001836807,"threshold_uncertainty_score":0.009714067,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00822250414208558,"score_gpt":0.2479474848772355,"score_spread":0.2397249807351499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}